Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation

J Antimicrob Chemother. 2022 Nov 28;77(12):3526-3527. doi: 10.1093/jac/dkac316.

Beatrijs Mertens^{1

2}, Ruth Van Daele^{1

2}, Yves Debaveye^{3

4}, Joost Wauters^{5

6}, Christophe Vandenbriele^{7

8}, Roger Brüggemann⁹, Matthias Gijsen^{1

2}, Isabel Spriet^{1

2}

¹ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
² Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
³ Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
⁴ Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
⁵ Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁶ Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
⁷ Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
⁸ Department of Adult Intensive Care, Royal Brompton & Harefield NHS Foundation Trust, London, UK.
⁹ Pharmacy Department, Radboud University Medical Center, Nijmegen, The Netherlands.

No abstract available

Publication types